# Acrivon Therapeutics, Inc.: Form 8-K, filed Sep 5, 2025

- Company: [Acrivon Therapeutics, Inc.](/companies/acrv.md) (CIK 1781174)
- Form: 8-K
- Filed: 2025-09-05
- Accepted by EDGAR: Sep 5, 2025, 16:25 ET
- Period: 2025-09-05
- Accession: 0001193125-25-197250
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1781174/000119312525197250/acrv-20250905.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1781174/000119312525197250/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1781174/000119312525197250/acrv-20250905.htm

Filed Sep 5, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-197250. Last ingested by Listed: Nov 11, 2026, 02:42 ET. No prices; not investment advice.